First Mercantile Trust Co Trimmed Quintiles Ims Holdings (Q) Position By $697,404; Madrigal Pharmaceuticals (MDGL) SI Increased By 15.47%

October 12, 2017 - By Hazel Jackson

Madrigal Pharmaceuticals Incorporated (NASDAQ:MDGL) had an increase of 15.47% in short interest. MDGL’s SI was 202,300 shares in October as released by FINRA. Its up 15.47% from 175,200 shares previously. With 22,200 avg volume, 9 days are for Madrigal Pharmaceuticals Incorporated (NASDAQ:MDGL)’s short sellers to cover MDGL’s short positions. The SI to Madrigal Pharmaceuticals Incorporated’s float is 4.23%. About 44,532 shares traded. Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) has 0.00% since October 12, 2016 and is . It has underperformed by 16.70% the S&P500.

First Mercantile Trust Co decreased Quintiles Ims Holdings Inc (Q) stake by 29.81% reported in 2017Q2 SEC filing. First Mercantile Trust Co sold 7,836 shares as Quintiles Ims Holdings Inc (Q)’s stock rose 8.21%. The First Mercantile Trust Co holds 18,453 shares with $1.65 million value, down from 26,289 last quarter. Quintiles Ims Holdings Inc now has $21.33 billion valuation. The stock rose 0.57% or $0.56 reaching $98.32. About 257,730 shares traded. Quintiles IMS Holdings Inc (NYSE:Q) has risen 27.93% since October 12, 2016 and is uptrending. It has outperformed by 11.23% the S&P500.




Among 22 analysts covering Quintiles Transnational (NYSE:Q), 9 have Buy rating, 0 Sell and 13 Hold. Therefore 41% are positive. Quintiles Transnational had 48 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was downgraded by Zacks to “Buy” on Tuesday, August 25. The stock of Quintiles IMS Holdings Inc (NYSE:Q) earned “Outperform” rating by Wells Fargo on Friday, February 17. The stock of Quintiles IMS Holdings Inc (NYSE:Q) earned “Buy” rating by UBS on Wednesday, October 5. The firm earned “Hold” rating on Monday, October 9 by Robert W. Baird. The firm earned “Hold” rating on Wednesday, October 19 by Jefferies. The rating was initiated by Avondale with “Sector Weight” on Wednesday, October 21. The firm has “Market Perform” rating given on Thursday, December 1 by William Blair. The rating was reinitiated by Credit Suisse with “Outperform” on Friday, August 14. The rating was upgraded by Robert W. Baird to “Neutral” on Friday, July 7. The stock of Quintiles IMS Holdings Inc (NYSE:Q) has “Hold” rating given on Thursday, August 3 by Stifel Nicolaus.

First Mercantile Trust Co increased Telephone And Data Systems (NYSE:TDS) stake by 20,519 shares to 38,699 valued at $1.07M in 2017Q2. It also upped Concho Resources Inc (NYSE:CXO) stake by 2,670 shares and now owns 12,979 shares. Akamai Technologies Inc (NASDAQ:AKAM) was raised too.

Investors sentiment increased to 0.93 in Q2 2017. Its up 0.11, from 0.82 in 2017Q1. It is positive, as 28 investors sold Q shares while 146 reduced holdings. 61 funds opened positions while 101 raised stakes. 199.95 million shares or 0.74% less from 201.43 million shares in 2017Q1 were reported. Holland Mngmt Ltd Liability Corp owns 1.01% invested in Quintiles IMS Holdings Inc (NYSE:Q) for 256,619 shares. Bp Public Ltd Com accumulated 11,000 shares or 0.04% of the stock. Longview Prns (Guernsey) reported 4.5% of its portfolio in Quintiles IMS Holdings Inc (NYSE:Q). The Netherlands-based Kempen Management Nv has invested 0.15% in Quintiles IMS Holdings Inc (NYSE:Q). Wcm Invest Ca has 682,664 shares for 0.94% of their portfolio. Us Bank De reported 43,156 shares or 0.01% of all its holdings. Bluecrest Cap Mgmt Ltd accumulated 40,394 shares or 0.14% of the stock. Aqr Capital Mngmt Ltd has 324,578 shares for 0.04% of their portfolio. Pitcairn invested in 0.03% or 2,700 shares. Chase Counsel Corp reported 63,411 shares or 2.76% of all its holdings. Fincl Partners Capital Limited Liability Corporation holds 1.59% in Quintiles IMS Holdings Inc (NYSE:Q) or 85,142 shares. Gulf Int Bankshares (Uk) Ltd reported 47,356 shares. Vision Cap stated it has 25,893 shares or 0.79% of all its holdings. Invesco Limited holds 0% or 19,886 shares. Bloom Tree Ptnrs Ltd holds 6.72% in Quintiles IMS Holdings Inc (NYSE:Q) or 678,823 shares.

Analysts await Quintiles IMS Holdings Inc (NYSE:Q) to report earnings on November, 1. They expect $1.14 earnings per share, up 14.00% or $0.14 from last year’s $1 per share. Q’s profit will be $247.32 million for 21.56 P/E if the $1.14 EPS becomes a reality. After $1.09 actual earnings per share reported by Quintiles IMS Holdings Inc for the previous quarter, Wall Street now forecasts 4.59% EPS growth.

Madrigal Pharmaceuticals, Inc., formerly Synta Pharmaceuticals Corp., is a clinical-stage biopharmaceutical company. The company has market cap of $619.91 million. The Firm focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis . It currently has negative earnings. The Company’s lead product, MGL-3196, is a Phase II-ready once-daily, oral, liver-directed selective thyroid hormone receptor-b (THR-b) agonist for the treatment of NASH, and heterozygous and homozygous familial hypercholesterolemia (FH).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts